White Paper
The Evolution and Impact of Pulmonary Arterial Hypertension Clinical Trial Educators
Redefining success in pulmonary hypertension clinical trials
Dec 29, 2025

Clinical trials in pulmonary arterial hypertension (PAH) highlight the need for tailored, patient-centric strategies—but these principles apply across all therapeutic areas. This whitepaper explores the critical role of multidisciplinary collaboration among sponsors, investigators, coordinators, and PAH patients—alongside the transformative impact of Clinical Trial Educators (CTEs).

Learn how IQVIA’s proven approach delivers “white glove” support for complex indications and can be adapted to any study setting.

Related solutions

Contact Us